Improved HPLC Method for Determination of Four PPIs, Omeprazole, Pantoprazole, Lansoprazole and Rabeprazole in Human Plasma

Improved HPLC Method for Determination of Four PPIs, Omeprazole, Pantoprazole, Lansoprazole and Rabeprazole in Human Plasma

ABSTRACT-PURPOSE: To develop a simple and rapid HPLC method for measuring of four proton-pump inhibitors (PPIs), omeprazole (OPZ), pantoprazole (PPZ), lansoprazole (LPZ) and rabeprazole (RPZ) concentrations in human plasma. METHODS: Following a single step liquid–liquid extraction analytes along wit...

Full description

Bibliographic Details
Main Authors:	Maryam Noubarani, Fariborz Keyhanfar, Manijeh Motevalian, Masoud Mahmoudian
Format:	Article
Language:	English
Published:	Canadian Society for Pharmaceutical Sciences 2010-01-01
Series:	Journal of Pharmacy & Pharmaceutical Sciences
Online Access:	https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/6871

Similar Items

Effect of food on the pharmacokinetics of omeprazole, pantoprazole and rabeprazole
by: Dolores Ochoa, et al.
Published: (2020-07-01)

Comparison of the Effect of Omeprazole, Pantoprazole, Esomeprazole, and Lansoprazole on the Reduction of Symptoms in Patients with Gastroesophageal Reflux Disease
by: Nima Arezoomandi, et al.
Published: (2019-02-01)

Métodos para a determinação enantiomérica dos fármacos omeprazol, lansoprazol e pantoprazol em águas residuais e de estuário
by: Vanzolini, Kenia Lourenço
Published: (2016)

Comparative study of Lansoprazole and Rabeprazole on ulcer healing property on albino rats
by: Amit Kumar Jha, et al.
Published: (2012-11-01)

Comparative study of Lansoprazole and Rabeprazole on ulcer healing property on albino rats
by: Amit Kumar Jha*
Published: (2012-01-01)

Comparison of the Effects of Omeprazole and Rabeprazole on Ticlopidine Metabolism In Vitro
by: Yuichi Kinoshita, et al.
Published: (2011-01-01)

Determination of Pantoprazole Sodium and Lansoprazole in Individual Tablet Dosage Forms by RP-HPLC Using Single Mobile Phase
by: B. Prasanna Kumar Reddy, et al.
Published: (2009-01-01)

Randomized trial comparing rabeprazole- versus lansoprazole-based Helicobacter pylori eradication regimens
by: Meng-Kwan Liu, et al.
Published: (2013-07-01)

PENGARUH LANSOPRAZOL DAN OMEPRAZOL TERHADAP AKTIVITAS ENZIM KATALASE HEPAR TIKUS
by: Eria Sartika, et al.
Published: (2016-10-01)

Omeprazole-induced and pantoprazole-induced asymptomatic hyponatremia: a case report
by: Isabel J. B. van der Zalm, et al.
Published: (2020-06-01)

Acute Hypersensitivity Reaction Related to use of Pantoprazole Lacking Cross-Reactivity with Omeprazole
by: Hemangini Rajanikant Acharya, et al.
Published: (2018-06-01)

Efeito do omeprazol e do pantoprazol sobre a regeneração hepática após hepatectomia parcial em ratos Effect of omeprazole and pantoprazole on liver regeneration after partial hepatectomy in rats
by: Gustavo Barreto de Melo, et al.
Published: (2003-12-01)

Differential effects of omeprazole and lansoprazole enantiomers on aryl hydrocarbon receptor in human hepatocytes and cell lines.
by: Aneta Novotna, et al.
Published: (2014-01-01)

Efficacy of <i>Helicobacter pylori</i> eradication therapy of infection with omeprazole and rabeprazole in overweight and obese patients
by: D. T. Dicheva, et al.
Published: (2020-05-01)

Analytical method development and validation of simultaneous estimation of rabeprazole, pantoprazole, and itopride by reverse-phase high-performance liquid chromatography
by: Senthamil Selvan Perumal, et al.
Published: (2014-12-01)

Effectifity and Cost Analysis of Omeprazole and Pantoprazole for Stress Related Mucosal Disease Prophylaxis in ICU
by: Dyah Atmi Tri Sukengtyas, et al.
Published: (2017-11-01)

Rabeprazole.
by: Desai C, et al.
Published: (2002-01-01)

Universal Quantifier PPIs
by: Hedde Zeijlstra
Published: (2017-10-01)

The comparison of oral omeprazole and intravenous pantoprazole effects in high risk upper gastrointestinal bleeding patients
by: Ahmad Shavakhi, et al.
Published: (2008-12-01)

A Validated HPLC-DAD Method for Simultaneous Determination of Etodolac and Pantoprazole in Rat Plasma
by: Ali S. Abdelhameed, et al.
Published: (2014-01-01)

HPLC Method Development and Validation for Simultaneous Analysis of Diclofenac Sodium and Rabeprazole Sodium
by: A. A. Heda, et al.
Published: (2010-01-01)

Development of RP-HPLC Method for the Estimation of Rabeprazole in Pure and Tablet Dosage Form
by: A. Lakshmana Rao, et al.
Published: (2008-01-01)

Gastroesophageal Reflux Disease Relief in Patients Treated with Rabeprazole 20 mg versus Omeprazole 20 mg: A Meta-Analysis
by: X. M. Xia, et al.
Published: (2013-01-01)

A modified high-performance liquid chromatographic method for the analysis of pantoprazole sodium in pharmaceutical dosage forms using lansoprazole as internal standard
by: Safwan Ashour, et al.
Published: (2016-09-01)

Perbandingan Efektivitas antara Omeprazol dan Lansoprazol terhadap Perbaikan Kualitas Hidup Penderita Rinosinusitis Kronik Akibat Refluks Laringofaring
by: Tantri Kurniawati, et al.
Published: (2012-09-01)

Rationalizing the use of PPIs: An unresolved matter
by: Julio Ponce, et al.
Published: (2013-03-01)

Modified PPIs (a search for the better)
by: Hussein Abdel-Hamid
Published: (2016-01-01)

Cost-effectiveness and cost–utility analysis of the use of clopidogrel and pantoprazole in comparison with clopidogrel and omeprazole for the secondary prevention of myocardial infarction in Iran
by: Mohammadreza Amirsadri, et al.
Published: (2021-01-01)

Impact of PPIs on patient focused symptomatology in GERD
by: ABR Thomson
Published: (2009-02-01)

A Simple and Validated Reverse Phase HPLC Methodfor the Determination of Rabeprazole inPharmaceutical Dosage Forms
by: Uma Mahesh Karra, et al.
Published: (2010-01-01)

Box-Behnken Assisted Validation and Optimization of an RP-HPLC Method for Simultaneous Determination of Domperidone and Lansoprazole
by: Mohd Afzal, et al.
Published: (2021-01-01)

Use of Rabeprazol in practice of gastroenterologist
by: Y. O. Shulpekova
Published: (2016-12-01)

Rebamipide with Proton Pump Inhibitors (PPIs) versus PPIs Alone for the Treatment of Endoscopic Submucosal Dissection-Induced Ulcers: A Meta-analysis
by: Junyuan Liu, et al.
Published: (2020-01-01)

Omeprazole and lansoprazole enantiomers induce CYP3A4 in human hepatocytes and cell lines via glucocorticoid receptor and pregnane X receptor axis.
by: Aneta Novotna, et al.
Published: (2014-01-01)

Development and Validation of RP-HPLC Method for the Simultaneous Determination of Rabeprazole Sodium and Itopride Hydrochloride in Solid Dosage Form
by: Rajesh Sharma, et al.
Published: (2010-01-01)

PPIs: between overuse and underprescription when really necessary
by: Carlos Martín-de-Argila-de-Prados, et al.
Published: (2015-11-01)

Proton Pump Inhibitors (PPIs): The culprit for Barrett’s esophagus?
by: Omran eAlsalahi, et al.
Published: (2015-01-01)

Stability of Lansoprazole in Oral Suspension
by: Morrison, J. T., et al.
Published: (2011)

Therapeutic Efficacy of Kangfuxin Liquid Combined with PPIs in Gastric Ulcer
by: Jun-Bo Zou, et al.
Published: (2019-01-01)

Stability-indicating HPLCâDAD methods for determination of two binary mixtures: Rabeprazole sodiumâmosapride citrate and rabeprazole sodiumâitopride hydrochloride
by: Hamed M. El-Fatatry, et al.
Published: (2014-08-01)